MHRA Plan To Raise Fees Will See Big Hike For Switch Applications
UK regulator MHRA has set out a proposal to raise fees across the board by at least 10% for its regulatory work related to medicines and medical devices. A select number of fees will see even bigger increases, with the cost almost tripling for Rx-to-OTC switch applications.
You may also be interested in...
The notices normally would go out on 1 August, but unspent user fee funds may be able to sustain work for a few weeks if the program expires.
Cosmetics and dietary supplement program reforms may have to wait if Republican Sen. Burr's stripped-down version of US FDA user-fee reauthorization package – which tracks with companion legislation already passed in the House – is the best Congress can do before the August recess.
Haleon has established its Centre for Human Sciences to foster collaboration between academics in human behavior and frontline healthcare professionals. The consumer health giant hopes the initiative will help solve some of the most pressing challenges facing healthcare professionals.